Article
Skeletal-Related Events in Patients With Multiple Myeloma and Prostate Cancer Who Receive Standard vs Extended-Interval Bisphosphonate Dosing
- Author:
- Abigail Shell, PharmD
- Leigh Anne Keough, PharmD, BCPS
- Kothanur Rajanna, PharmD
In patients with multiple myeloma and prostate cancer, extending the bisphosphonatedosing interval may help decrease medication-related morbidity...